Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Deborah L. Fretwell"'
Autor:
William M. Wood, Vibha Sharma, Kevin T. Bauerle, Laura A. Pike, Qiong Zhou, Deborah L. Fretwell, Rebecca E. Schweppe, Bryan R. Haugen
Publikováno v:
PPAR Research, Vol 2011 (2011)
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγ levels are elevated in cells derived from ATC. Depletion of PPARγ in HTh74
Externí odkaz:
https://doaj.org/article/73f136048bcd471a8389a23be980c795
Publikováno v:
Journal of cardiothoracic and vascular anesthesia. 34(5)
Autor:
Deborah L. Fretwell, Luis M. Rivera
Publikováno v:
Clinical Anesthesiology II ISBN: 9783030123635
We present the case of a 70-year-old man who was found obtunded in his skilled nursing facility (SNF) and was transported by ambulance to the emergency department (ED) while being ventilated by mask. His past medical history was significant for HIV/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::698a2a749a06c1914fa6ab15c830d598
https://doi.org/10.1007/978-3-030-12365-9_4
https://doi.org/10.1007/978-3-030-12365-9_4
Autor:
Rebecca E. Schweppe, Deborah L. Fretwell, Qiong Zhou, Laura A. Pike, William M. Wood, Bryan R. Haugen, Kevin T. Bauerle, Vibha Sharma
Publikováno v:
PPAR Research, Vol 2011 (2011)
PPAR Research
PPAR Research
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγlevels are elevated in cells derived from ATC. Depletion of PPARγin HTh74 AT
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 20(10)
The vitamin D receptor (VDR) has been studied as a novel target for cancer therapy in many tissue types as VDR ligands decrease cell proliferation in vitro and decrease tumor growth in vivo in sensitive cells. The objective of this study was to analy
Autor:
Zachary Weber, Joshua P. Klopper, Bryan R. Haugen, Jena D. French, Deborah L. Fretwell, Sherif Said
Publikováno v:
The Journal of clinical endocrinology and metabolism. 95(5)
Context: Ten to 30% of patients with papillary thyroid cancer (PTC) develop recurrent disease and may benefit from innovative adjuvant therapies. Immune-based therapies are under investigation to treat many types of cancer. The role of the immune sys